Their study found that the mast cell mediated effects occur as a result of activation of TβRI signaling, promoting tumor cell regrowth. This suggests that tumor-infiltrating myeloid cells contribute to the development, progression, and resistance to treatment observed in patients with PDAC. This evidence concerns the gene TGFBR1 and neoplasm.